HLA-DQ2-gliadin tetramer

· Oslo University Hospital

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HLA-DQ2-gliadin tetramer, covering 2012-09-19 to 2012-09-19. Get the full timeline:

Most recent: Clinical Trial Update: HLA-DQ2-gliadin Tetramer for Diagnosis of Celiac Disease [Phase 2, Phase 3]